C12Y 503/99003
Prostaglandin-e synthase
Official title: Prostaglandin-E synthase (5.3.99.3)
C12Y503/99003 (Prostaglandin-e synthase) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 5
- Inventors
- 15
- Latest grant
- 14 Jul 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Regeneration or rejuvenation of tissues and organs2 Jan 2025US 2025/0002919 A1The Board of Trustees of the Leland Stanford Junior University
- Method of selectively inhibiting mpges-17 Mar 2019US 2019/0070170 A1Macau University of Science and Technology
- Modeling of mPGES-1 three-dimensional structures: applications in drug design and discovery24 Nov 2011US 2011/0288844 A1University of Kentucky Research Foundation
- Peripheral and neural inflammatory crosstalk11 Nov 2010US 2010/0286233 A1University of Rochester
- Modeling of mPGES-1 three-dimensional structures: applications in drug design and discovery24 Jul 2008US 2008/0177521 A1University of Kentucky
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.